{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:29:32Z","timestamp":1792099772149,"version":"4.4.0"},"reference-count":117,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2016,2,10]],"date-time":"2016-02-10T00:00:00Z","timestamp":1455062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100002996","name":"Dutch Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Renal dysfunction in heart failure with preserved ejection fraction (HFpEF) is common and is associated with increased mortality. Impaired renal function is also a risk factor for developing HFpEF. A new paradigm for HFpEF, proposing a sequence of events leading to myocardial remodelling and dysfunction in HFpEF, was recently introduced, involving inflammatory, microvascular, and cardiac components. The kidney might play a key role in this systemic process. Renal impairment causes metabolic and systemic derangements in circulating factors, causing an activated systemic inflammatory state and endothelial dysfunction, which may lead to cardiomyocyte stiffening, hypertrophy, and interstitial fibrosis via cross-talk between the endothelium and cardiomyocyte compartments. Here, we review the role of endothelial dysfunction and inflammation to explain the link between renal dysfunction and HFpEF, which allows for identification of new early risk markers, prognostic factors, and unique targets for intervention.<\/jats:p>","DOI":"10.1002\/ejhf.497","type":"journal-article","created":{"date-parts":[[2016,2,10]],"date-time":"2016-02-10T05:55:29Z","timestamp":1455083729000},"page":"588-598","source":"Crossref","is-referenced-by-count":293,"title":["Connecting Heart Failure with Preserved Ejection Fraction and Renal Dysfunction: The Role of endothelial Dysfunction and Inflammation"],"prefix":"10.1093","volume":"18","author":[{"given":"Jozine M.","family":"ter Maaten","sequence":"first","affiliation":[{"name":"University of Groningen, Department of Cardiology, University Medical Center Groningen , Groningen ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Damman","sequence":"additional","affiliation":[{"name":"University of Groningen, Department of Cardiology, University Medical Center Groningen , Groningen ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne C.","family":"Verhaar","sequence":"additional","affiliation":[{"name":"University Medical Center Utrecht, Department of Nephrology and Hypertension , Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter J.","family":"Paulus","sequence":"additional","affiliation":[{"name":"Department of Physiology, Cardiology, Pathology, and Surgery, Institute for Cardiovascular Research, VU University Medical Center , Amsterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk J.","family":"Duncker","sequence":"additional","affiliation":[{"name":"Experimental Cardiology, Department of Cardiology, Thoraxcenter, Erasmus University Medical Center , Rotterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Cheng","sequence":"additional","affiliation":[{"name":"University Medical Center Utrecht, Department of Nephrology and Hypertension , Utrecht ,","place":["The Netherlands"]},{"name":"Experimental Cardiology, Department of Cardiology, Thoraxcenter, Erasmus University Medical Center , Rotterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loek","family":"van Heerebeek","sequence":"additional","affiliation":[{"name":"Department of Physiology, Cardiology, Pathology, and Surgery, Institute for Cardiovascular Research, VU University Medical Center , Amsterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans L.","family":"Hillege","sequence":"additional","affiliation":[{"name":"University of Groningen, Department of Epidemiology, University Medical Center Groningen , Groningen ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn S.P.","family":"Lam","sequence":"additional","affiliation":[{"name":"National Heart Centre Singapore and, Duke-National University of Singapore Graduate School Medicine \u00a0","place":["Singapore"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerjan","family":"Navis","sequence":"additional","affiliation":[{"name":"University of Groningen, Department of Nephrology, University Medical Center Groningen , Groningen ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriaan A.","family":"Voors","sequence":"additional","affiliation":[{"name":"University of Groningen, Department of Cardiology, University Medical Center Groningen , Groningen ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,2,10]]},"reference":[{"key":"2026011721151127200_ejhf497-bib-0001","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.jacc.2012.01.077","article-title":"Cardiorenal syndrome type 1: pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure","volume":"60","author":"Ronco","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2026011721151127200_ejhf497-bib-0002","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000349972","article-title":"Cardiorenal syndrome type 4: insights on clinical presentation and pathophysiology from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI)","volume":"182","author":"Tumlin","year":"2013","journal-title":"Contrib Nephrol"},{"key":"2026011721151127200_ejhf497-bib-0003","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1093\/eurheartj\/ehs205","article-title":"The role of the kidney in heart failure","volume":"33","author":"Metra","year":"2012","journal-title":"Eur Heart J"},{"key":"2026011721151127200_ejhf497-bib-0004","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jacc.2011.11.040","article-title":"Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction","volume":"59","author":"Ather","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2026011721151127200_ejhf497-bib-0005","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jacc.2005.09.022","article-title":"Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database","volume":"47","author":"Yancy","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2026011721151127200_ejhf497-bib-0006","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/eurjhf\/hfq121","article-title":"Epidemiology and clinical course of heart failure with preserved ejection fraction","volume":"13","author":"Lam","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"2026011721151127200_ejhf497-bib-0007","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1093\/eurheartj\/eht066","article-title":"Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND","volume":"34","author":"Brouwers","year":"2013","journal-title":"Eur Heart J"},{"key":"2026011721151127200_ejhf497-bib-0008","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/CIRCHEARTFAILURE.111.966242","article-title":"Renal dysfunction in patients with heart failure with preserved versus reduced ejection fraction: impact of the new Chronic Kidney Disease-Epidemiology Collaboration Group formula","volume":"5","author":"McAlister","year":"2012","journal-title":"Circ Heart Fail"},{"key":"2026011721151127200_ejhf497-bib-0009","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1093\/eurheartj\/ehu254","article-title":"Association between renal function and cardiovascular structure and function in heart failure with preserved ejection fraction","volume":"35","author":"Gori","year":"2014","journal-title":"Eur Heart J"},{"key":"2026011721151127200_ejhf497-bib-0010","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1161\/CIRCULATIONAHA.105.580506","article-title":"Renal function as a predictor of outcome in a broad spectrum of patients with heart failure","volume":"113","author":"Hillege","year":"2006","journal-title":"Circulation"},{"key":"2026011721151127200_ejhf497-bib-0011","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/eurheartj\/eht386","article-title":"Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis","volume":"35","author":"Damman","year":"2014","journal-title":"Eur Heart J"},{"key":"2026011721151127200_ejhf497-bib-0012","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1161\/CIRCULATIONAHA.114.010637","article-title":"Phenomapping for novel classification of heart failure with preserved ejection fraction","volume":"131","author":"Shah","year":"2015","journal-title":"Circulation"},{"key":"2026011721151127200_ejhf497-bib-0013","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/eurheartj\/ehv010","article-title":"The kidney in heart failure: an update","volume":"36","author":"Damman","year":"2015","journal-title":"Eur Heart J"},{"key":"2026011721151127200_ejhf497-bib-0014","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/ejhf.232","article-title":"Renal effects of the angiotensin receptor neprilysin inhibitor LCZ696 in patients with heart failure and preserved ejection fraction","volume":"17","author":"Voors","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"2026011721151127200_ejhf497-bib-0015","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.jacc.2014.01.087","article-title":"Worsening renal function and outcome in heart failure patients with preserved ejection fraction and the impact of angiotensin receptor blocker treatment","volume":"64","author":"Damman","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2026011721151127200_ejhf497-bib-0016","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ijcard.2009.09.529","article-title":"Renal function and long-term survival after hospital discharge in heart failure with preserved ejection fraction","volume":"147","author":"Rusinaru","year":"2011","journal-title":"Int J Cardiol"},{"key":"2026011721151127200_ejhf497-bib-0017","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cardfail.2007.09.002","article-title":"Cystatin C concentration as a predictor of systolic and diastolic heart failure","volume":"14","author":"Moran","year":"2008","journal-title":"J Card Fail"},{"key":"2026011721151127200_ejhf497-bib-0018","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1161\/CIRCULATIONAHA.108.815944","article-title":"Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the Framingham Heart Study of the National Heart, Lung, and Blood Institute","volume":"119","author":"Lee","year":"2009","journal-title":"Circulation"},{"key":"2026011721151127200_ejhf497-bib-0019","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1161\/CIRCULATIONAHA.109.929661","article-title":"Multimarker approach for the prediction of heart failure incidence in the community","volume":"122","author":"Velagaleti","year":"2010","journal-title":"Circulation"},{"key":"2026011721151127200_ejhf497-bib-0020","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1152\/physrev.00017.2002","article-title":"Cardiac endothelial\u2013myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity","volume":"83","author":"Brutsaert","year":"2003","journal-title":"Physiol Rev"},{"key":"2026011721151127200_ejhf497-bib-0021","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1089\/ars.2008.2220","article-title":"NADPH oxidase-dependent signaling in endothelial cells: role in physiology and pathophysiology","volume":"11","author":"Frey","year":"2009","journal-title":"Antioxid Redox Signal"},{"key":"2026011721151127200_ejhf497-bib-0022","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1016\/j.jacc.2014.02.572","article-title":"Endothelial NADPH oxidase-2 promotes interstitial cardiac fibrosis and diastolic dysfunction through proinflammatory effects and endothelial\u2013mesenchymal transition","volume":"63","author":"Murdoch","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2026011721151127200_ejhf497-bib-0023","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1161\/01.RES.86.5.494","article-title":"NAD(P)H oxidase: role in cardiovascular biology and disease","volume":"86","author":"Griendling","year":"2000","journal-title":"Circ Res"},{"key":"2026011721151127200_ejhf497-bib-0024","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1001\/jama.1996.03540140077033","article-title":"The 1996 Albert Lasker Medical Research Awards. Signal transduction using nitric oxide and cyclic guanosine monophosphate","volume":"276","author":"Murad","year":"1996","journal-title":"JAMA"},{"key":"2026011721151127200_ejhf497-bib-0025","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1161\/01.CIR.92.8.2119","article-title":"Paracrine coronary endothelial control of left ventricular function in humans","volume":"92","author":"Paulus","year":"1995","journal-title":"Circulation"},{"key":"2026011721151127200_ejhf497-bib-0026","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1161\/01.RES.62.2.358","article-title":"Effects of damaging the endocardial surface on the mechanical performance of isolated cardiac muscle","volume":"62","author":"Brutsaert","year":"1988","journal-title":"Circ Res"},{"key":"2026011721151127200_ejhf497-bib-0027","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00424-011-1038-y","article-title":"Firewall function of the endothelial glycocalyx in the regulation of sodium homeostasis","volume":"463","author":"Korte","year":"2012","journal-title":"Pflugers Arch"},{"key":"2026011721151127200_ejhf497-bib-0028","first-page":"20","volume":"4","author":"Kusche-Vihrog","year":"2012","journal-title":"An emerging concept of vascular salt sensitivity. F1000 Biol Rep"},{"key":"2026011721151127200_ejhf497-bib-0029","doi-asserted-by":"crossref","first-page":"16281","DOI":"10.1073\/pnas.0707791104","article-title":"Plasma sodium stiffens vascular endothelium and reduces nitric oxide release","volume":"104","author":"Oberleithner","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026011721151127200_ejhf497-bib-0030","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s00424-007-0341-0","article-title":"Aldosterone and amiloride alter ENaC abundance in vascular endothelium","volume":"455","author":"Kusche-Vihrog","year":"2008","journal-title":"Pflugers Arch"},{"key":"2026011721151127200_ejhf497-bib-0031","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.jacc.2012.08.004","article-title":"Endothelial dysfunction: a pathophysiologic factor in heart failure with preserved ejection fraction","volume":"60","author":"Lam","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2026011721151127200_ejhf497-bib-0032","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jacc.2010.03.077","article-title":"Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction","volume":"56","author":"Borlaug","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026011721151127200_ejhf497-bib-0033","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/j.jacc.2012.07.036","article-title":"Incremental prognostic significance of peripheral endothelial dysfunction in patients with heart failure with normal left ventricular ejection fraction","volume":"60","author":"Akiyama","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2026011721151127200_ejhf497-bib-0034","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1161\/CIRCULATIONAHA.114.009625","article-title":"Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction","volume":"131","author":"Mohammed","year":"2015","journal-title":"Circulation"},{"key":"2026011721151127200_ejhf497-bib-0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4161\/org.6.1.10427","article-title":"Microvascular rarefaction: the decline and fall of blood vessels","volume":"6","author":"Goligorsky","year":"2010","journal-title":"Organogenesis"},{"key":"2026011721151127200_ejhf497-bib-0036","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1161\/CIRCULATIONAHA.114.014420","article-title":"What the dead can teach the living: systemic nature of heart failure with preserved ejection fraction","volume":"131","author":"Kitzman","year":"2015","journal-title":"Circulation"},{"key":"2026011721151127200_ejhf497-bib-0037","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/00004872-200502000-00001","article-title":"Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension","volume":"23","author":"Brunner","year":"2005","journal-title":"J Hypertens"},{"key":"2026011721151127200_ejhf497-bib-0038","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081798","article-title":"Obesity is associated with lower coronary microvascular density","volume":"8","author":"Campbell","year":"2013","journal-title":"PLoS One"},{"key":"2026011721151127200_ejhf497-bib-0039","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2174\/157016108785909779","article-title":"The cardiac microvasculature in hypertension, cardiac hypertrophy and diastolic heart failure","volume":"6","author":"Hoenig","year":"2008","journal-title":"Curr Vasc Pharmacol"},{"key":"2026011721151127200_ejhf497-bib-0040","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s10741-013-9405-8","article-title":"Role of inflammation in the pathogenesis of heart failure with preserved ejection fraction and its potential as a therapeutic target","volume":"19","author":"Glezeva","year":"2014","journal-title":"Heart Fail Rev"},{"key":"2026011721151127200_ejhf497-bib-0041","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.jacc.2009.12.045","article-title":"Inflammatory markers and incident heart failure risk in older adults: the Health ABC (Health, Aging, and Body Composition) study","volume":"55","author":"Kalogeropoulos","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026011721151127200_ejhf497-bib-0042","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/eurjhf\/hfr079","article-title":"Can emerging biomarkers of myocardial remodelling identify asymptomatic hypertensive patients at risk for diastolic dysfunction and diastolic heart failure?","volume":"13","author":"Collier","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"2026011721151127200_ejhf497-bib-0043","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1373\/clinchem.2010.159277","article-title":"Prognostic utility of ST2 in patients with acute dyspnea and preserved left ventricular ejection fraction","volume":"57","author":"Shah","year":"2011","journal-title":"Clin Chem"},{"key":"2026011721151127200_ejhf497-bib-0044","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jacc.2010.10.018","article-title":"Pentraxin 3 is a new inflammatory marker correlated with left ventricular diastolic dysfunction and heart failure with normal ejection fraction","volume":"57","author":"Matsubara","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2026011721151127200_ejhf497-bib-0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099495","article-title":"Circulating levels of tumor necrosis factor-alpha receptor 2 are increased in heart failure with preserved ejection fraction relative to heart failure with reduced ejection fraction: evidence for a divergence in pathophysiology","volume":"9","author":"Putko","year":"2014","journal-title":"PLoS One"},{"key":"2026011721151127200_ejhf497-bib-0046","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1161\/CIRCULATIONAHA.111.076075","article-title":"Low myocardial protein kinase G activity in heart failure with preserved ejection fraction","volume":"126","author":"van Heerebeek","year":"2012","journal-title":"Circulation"},{"key":"2026011721151127200_ejhf497-bib-0047","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026011721151127200_ejhf497-bib-0048","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1089\/ars.2007.1989","article-title":"Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension","volume":"10","author":"Schulz","year":"2008","journal-title":"Antioxid Redox Signal"},{"key":"2026011721151127200_ejhf497-bib-0049","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1161\/CIRCRESAHA.117.305349","article-title":"Cardiac nonmyocytes in the hub of cardiac hypertrophy","volume":"117","author":"Kamo","year":"2015","journal-title":"Circ Res"},{"key":"2026011721151127200_ejhf497-bib-0050","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.hfc.2014.03.001","article-title":"Invasive hemodynamic characterization of heart failure with preserved ejection fraction","volume":"10","author":"Andersen","year":"2014","journal-title":"Heart Fail Clin"},{"key":"2026011721151127200_ejhf497-bib-0051","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.ejheart.2007.05.010","article-title":"Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction","volume":"9","author":"Damman","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"2026011721151127200_ejhf497-bib-0052","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jacc.2008.05.068","article-title":"Importance of venous congestion for worsening of renal function in advanced decompensated heart failure","volume":"53","author":"Mullens","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026011721151127200_ejhf497-bib-0053","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jacc.2008.08.080","article-title":"Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease","volume":"53","author":"Damman","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026011721151127200_ejhf497-bib-0054","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.pcad.2011.01.003","article-title":"The cardiorenal syndrome in heart failure","volume":"54","author":"Damman","year":"2011","journal-title":"Prog Cardiovasc Dis"},{"key":"2026011721151127200_ejhf497-bib-0055","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1093\/eurheartj\/ehu193","article-title":"Right heart dysfunction in heart failure with preserved ejection fraction","volume":"35","author":"Melenovsky","year":"2014","journal-title":"Eur Heart J"},{"key":"2026011721151127200_ejhf497-bib-0056","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1093\/eurjhf\/hft026","article-title":"Cardiac output response to exercise in relation to metabolic demand in heart failure with preserved ejection fraction","volume":"15","author":"Abudiab","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"2026011721151127200_ejhf497-bib-0057","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1161\/CIRCULATIONAHA.106.632745","article-title":"Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction","volume":"114","author":"Borlaug","year":"2006","journal-title":"Circulation"},{"key":"2026011721151127200_ejhf497-bib-0058","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1161\/01.CIR.0000048123.22359.A0","article-title":"Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve limitations","volume":"107","author":"Kawaguchi","year":"2003","journal-title":"Circulation"},{"key":"2026011721151127200_ejhf497-bib-0059","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jacc.2011.09.062","article-title":"Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy","volume":"59","author":"Schwartzenberg","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2026011721151127200_ejhf497-bib-0060","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.amjcard.2015.06.038","article-title":"Association of chronic kidney disease with chronotropic incompetence in heart failure with preserved ejection fraction","volume":"116","author":"Klein","year":"2015","journal-title":"Am J Cardiol"},{"key":"2026011721151127200_ejhf497-bib-0061","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ccl.2011.06.004","article-title":"Ventricular\u2013vascular interaction in heart failure","volume":"29","author":"Borlaug","year":"2011","journal-title":"Cardiol Clin"},{"key":"2026011721151127200_ejhf497-bib-0062","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1161\/01.CIR.69.1.57","article-title":"Relationship between central hemodynamics and regional blood flow in normal subjects and in patients with congestive heart failure","volume":"69","author":"Leithe","year":"1984","journal-title":"Circulation"},{"issue":"4","key":"2026011721151127200_ejhf497-bib-0063","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2165\/00003495-199000394-00004","article-title":"Role of the kidney in congestive heart failure. Relationship of cardiac index to kidney function","volume":"39","author":"Ljungman","year":"1990","journal-title":"Drugs"},{"key":"2026011721151127200_ejhf497-bib-0064","doi-asserted-by":"crossref","first-page":"R1449","DOI":"10.1152\/ajpregu.00440.2010","article-title":"Renal cortical and medullary blood flow responses to altered NO availability in humans","volume":"299","author":"Damkjaer","year":"2010","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2026011721151127200_ejhf497-bib-0065","volume-title":"Medical Physiology","author":"Guyton","year":"2006","edition":"11th ed."},{"key":"2026011721151127200_ejhf497-bib-0066","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1093\/ndt\/gft065","article-title":"Fibroblast growth factor-23: what we know, what we don\u2019t know, and what we need to know","volume":"28","author":"Kovesdy","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"2026011721151127200_ejhf497-bib-0067","doi-asserted-by":"crossref","first-page":"E426","DOI":"10.1152\/ajpendo.00264.2014","article-title":"FGF23 directly impairs endothelium-dependent vasorelaxation by increasing superoxide levels and reducing nitric oxide bioavailability","volume":"307","author":"Silswal","year":"2014","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2026011721151127200_ejhf497-bib-0068","doi-asserted-by":"crossref","first-page":"c384","DOI":"10.1159\/000323664","article-title":"Hypovitaminosis D is associated with systemic inflammation and concentric myocardial geometric pattern in hemodialysis patients with low iPTH levels","volume":"118","author":"Bucharles","year":"2011","journal-title":"Nephron Clin Pract"},{"key":"2026011721151127200_ejhf497-bib-0069","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.atherosclerosis.2011.10.023","article-title":"Vitamin D deficiency and endothelial dysfunction in non-dialysis chronic kidney disease patients","volume":"220","author":"Chitalia","year":"2012","journal-title":"Atherosclerosis"},{"key":"2026011721151127200_ejhf497-bib-0070","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1046\/j.1523-1755.1999.00575.x","article-title":"Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure","volume":"56","author":"Rostand","year":"1999","journal-title":"Kidney Int"},{"key":"2026011721151127200_ejhf497-bib-0071","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1093\/ndt\/gfp749","article-title":"Progenitor cells and vascular function are impaired in patients with chronic kidney disease","volume":"25","author":"Jie","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"2026011721151127200_ejhf497-bib-0072","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/j.jacc.2007.12.048","article-title":"Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) study","volume":"51","author":"Bahrami","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2026011721151127200_ejhf497-bib-0073","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.amjcard.2005.05.052","article-title":"Relation of microalbuminuria to adiponectin and augmented C-reactive protein levels in men with essential hypertension","volume":"96","author":"Tsioufis","year":"2005","journal-title":"Am J Cardiol"},{"key":"2026011721151127200_ejhf497-bib-0074","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1681\/ASN.2007040461","article-title":"ADMA levels correlate with proteinuria, secondary amyloidosis, and endothelial dysfunction","volume":"19","author":"Yilmaz","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"2026011721151127200_ejhf497-bib-0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116160","article-title":"Endothelial nitric oxide synthase single nucleotide polymorphism and left ventricular function in early chronic kidney disease","volume":"10","author":"Chand","year":"2015","journal-title":"PLoS One"},{"key":"2026011721151127200_ejhf497-bib-0076","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1097\/HJH.0000000000000210","article-title":"Sympathetic activation secondary to chronic kidney disease: therapeutic target for renal denervation?","volume":"32","author":"de Beus","year":"2014","journal-title":"J Hypertens"},{"key":"2026011721151127200_ejhf497-bib-0077","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0735-1097(01)01786-7","article-title":"Sympathetic activation markedly reduces endothelium-dependent, flow-mediated vasodilation","volume":"39","author":"Hijmering","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"2026011721151127200_ejhf497-bib-0078","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117332","article-title":"A systematic review concerning the relation between the sympathetic nervous system and heart failure with preserved left ventricular ejection fraction","volume":"10","author":"Verloop","year":"2015","journal-title":"PLoS One"},{"key":"2026011721151127200_ejhf497-bib-0079","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1001\/jama.288.17.2144","article-title":"Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure","volume":"288","author":"Kitzman","year":"2002","journal-title":"JAMA"},{"key":"2026011721151127200_ejhf497-bib-0080","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000351758","article-title":"Cardiovascular burden associated with uremic toxins in patients with chronic kidney disease","volume":"38","author":"Moradi","year":"2013","journal-title":"Am J Nephrol"},{"key":"2026011721151127200_ejhf497-bib-0081","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1159\/000191468","article-title":"Indoxyl sulfate inhibits nitric oxide production and cell viability by inducing oxidative stress in vascular endothelial cells","volume":"29","author":"Tumur","year":"2009","journal-title":"Am J Nephrol"},{"key":"2026011721151127200_ejhf497-bib-0082","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1038\/sj.ki.5000340","article-title":"Indoxyl sulfate stimulates proliferation of rat vascular smooth muscle cells","volume":"69","author":"Yamamoto","year":"2006","journal-title":"Kidney Int"},{"key":"2026011721151127200_ejhf497-bib-0083","doi-asserted-by":"crossref","first-page":"F1381","DOI":"10.1152\/ajprenal.00003.2008","article-title":"Increased inorganic phosphate induces human endothelial cell apoptosis in vitro","volume":"294","author":"Di Marco","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"key":"2026011721151127200_ejhf497-bib-0084","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1210\/en.2006-1691","article-title":"Mineralocorticoid receptor blockade attenuates chronic overexpression of the renin\u2013angiotensin\u2013aldosterone system stimulation of reduced nicotinamide adenine dinucleotide phosphate oxidase and cardiac remodeling","volume":"148","author":"Stas","year":"2007","journal-title":"Endocrinology"},{"key":"2026011721151127200_ejhf497-bib-0085","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrcardio.2013.15","article-title":"Management of cardiovascular disease in patients with kidney disease","volume":"10","author":"Kahn","year":"2013","journal-title":"Nat Rev Cardiol"},{"key":"2026011721151127200_ejhf497-bib-0086","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3109\/10715762.2013.779373","article-title":"Oxidative stress in patients with cardiovascular disease and chronic renal failure","volume":"47","author":"Popolo","year":"2013","journal-title":"Free Radic Res"},{"key":"2026011721151127200_ejhf497-bib-0087","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/ki.1995.325","article-title":"Impaired endothelial function in patients with nephrotic range proteinuria","volume":"48","author":"Stroes","year":"1995","journal-title":"Kidney Int"},{"issue":"Suppl 2","key":"2026011721151127200_ejhf497-bib-0088","first-page":"14","article-title":"Endothelium-dependent vasodilatation and distensibility of large arteries in chronic haemodialysis patients","volume":"12","author":"van Guldener","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"2026011721151127200_ejhf497-bib-0089","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1046\/j.1523-1755.2001.00059.x","article-title":"Acute administration of L-arginine does not improve arterial endothelial function in chronic renal failure","volume":"60","author":"Cross","year":"2001","journal-title":"Kidney Int"},{"key":"2026011721151127200_ejhf497-bib-0090","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1161\/CIRCHEARTFAILURE.113.001041","article-title":"Arterial stiffness, central pressures, and incident hospitalized heart failure in the chronic renal insufficiency cohort study","volume":"7","author":"Chirinos","year":"2014","journal-title":"Circ Heart Fail"},{"key":"2026011721151127200_ejhf497-bib-0091","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2215\/CJN.07761109","article-title":"Left ventricular hypertrophy in new hemodialysis patients without symptomatic cardiac disease","volume":"5","author":"Foley","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026011721151127200_ejhf497-bib-0092","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2215\/CJN.03170707","article-title":"Hemodialysis-induced cardiac dysfunction is associated with an acute reduction in global and segmental myocardial blood flow","volume":"3","author":"McIntyre","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026011721151127200_ejhf497-bib-0093","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1053\/j.ajkd.2013.11.010","article-title":"Hemodialysis-induced regional left ventricular systolic dysfunction and inflammation: a cross-sectional study","volume":"64","author":"Assa","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"2026011721151127200_ejhf497-bib-0094","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0161-5890(03)00105-6","article-title":"Complement and renal disease","volume":"40","author":"Trouw","year":"2003","journal-title":"Mol Immunol"},{"key":"2026011721151127200_ejhf497-bib-0095","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1053\/j.ajkd.2004.02.008","article-title":"Advanced glycation end products in kidney transplant patients: a putative role in the development of chronic renal transplant dysfunction","volume":"43","author":"Hartog","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"2026011721151127200_ejhf497-bib-0096","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1046\/j.1525-139X.2002.00083.x","article-title":"Inflammation in end-stage renal disease: sources, consequences, and therapy","volume":"15","author":"Stenvinkel","year":"2002","journal-title":"Semin Dial"},{"key":"2026011721151127200_ejhf497-bib-0097","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.2174\/0929867043364342","article-title":"The clinical relevance of advanced glycation endproducts (AGE) and recent developments in pharmaceutics to reduce AGE accumulation","volume":"11","author":"Smit","year":"2004","journal-title":"Curr Med Chem"},{"key":"2026011721151127200_ejhf497-bib-0098","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1006\/jmcc.2002.2084","article-title":"Advanced glycation endproduct-induced calcium handling impairment in mouse cardiac myocytes","volume":"34","author":"Petrova","year":"2002","journal-title":"J Mol Cell Cardiol"},{"key":"2026011721151127200_ejhf497-bib-0099","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.ejheart.2007.09.009","article-title":"Advanced glycation end-products (AGEs) and heart failure: pathophysiology and clinical implications","volume":"9","author":"Hartog","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"2026011721151127200_ejhf497-bib-0100","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0033-0620(96)80002-8","article-title":"Endothelial function in different organs","volume":"39","author":"Bassenge","year":"1996","journal-title":"Prog Cardiovasc Dis"},{"key":"2026011721151127200_ejhf497-bib-0101","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1681\/ASN.2012090909","article-title":"Elevated galectin-3 precedes the development of CKD","volume":"24","author":"O\u2019Seaghdha","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"2026011721151127200_ejhf497-bib-0102","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jacc.2012.04.053","article-title":"Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community","volume":"60","author":"Ho","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2026011721151127200_ejhf497-bib-0103","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1161\/01.CIR.0000147181.65298.4D","article-title":"Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction","volume":"110","author":"Sharma","year":"2004","journal-title":"Circulation"},{"key":"2026011721151127200_ejhf497-bib-0104","doi-asserted-by":"crossref","first-page":"F500","DOI":"10.1152\/ajprenal.00461.2014","article-title":"Pharmacological inhibition of galectin-3 protects against hypertensive nephropathy","volume":"308","author":"Frenay","year":"2015","journal-title":"Am J Physiol Renal Physiol"},{"key":"2026011721151127200_ejhf497-bib-0105","doi-asserted-by":"crossref","first-page":"288","DOI":"10.2353\/ajpath.2008.070726","article-title":"Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis","volume":"172","author":"Henderson","year":"2008","journal-title":"Am J Pathol"},{"key":"2026011721151127200_ejhf497-bib-0106","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jchf.2014.10.009","article-title":"Galectin-3 in heart failure with preserved ejection fraction. A RELAX trial substudy (Phosphodiesterase-5 Inhibition to Improve Clinical Status and Exercise Capacity in Diastolic Heart Failure)","volume":"3","author":"AbouEzzeddine","year":"2015","journal-title":"JACC Heart Fail"},{"key":"2026011721151127200_ejhf497-bib-0107","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/j.jacc.2015.07.067","article-title":"Sodium nitrite improves exercise hemodynamics and ventricular performance in heart failure with preserved ejection fraction","volume":"66","author":"Borlaug","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2026011721151127200_ejhf497-bib-0108","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1093\/eurheartj\/ehs100","article-title":"Chronic therapy with isosorbide-5-mononitrate causes endothelial dysfunction, oxidative stress, and a marked increase in vascular endothelin-1 expression","volume":"34","author":"Oelze","year":"2013","journal-title":"Eur Heart J"},{"key":"2026011721151127200_ejhf497-bib-0109","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1056\/NEJMoa1510774","article-title":"Isosorbide mononitrate in heart failure with preserved ejection fraction","volume":"373","author":"Redfield","year":"2015","journal-title":"N Engl J Med"},{"key":"2026011721151127200_ejhf497-bib-0110","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00424-007-0212-8","article-title":"The endothelial glycocalyx: composition, functions, and visualization","volume":"454","author":"Reitsma","year":"2007","journal-title":"Pflugers Arch"},{"key":"2026011721151127200_ejhf497-bib-0111","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000357641","article-title":"Effects of AST-120 on blood concentrations of protein-bound uremic toxins and biomarkers of cardiovascular risk in chronic dialysis patients","volume":"37","author":"Lee","year":"2014","journal-title":"Blood Purif"},{"key":"2026011721151127200_ejhf497-bib-0112","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cardfail.2010.07.248","article-title":"Prognostic value of cystatin C on admission in heart failure with preserved ejection fraction","volume":"17","author":"Carrasco-Sanchez","year":"2011","journal-title":"J Card Fail"},{"key":"2026011721151127200_ejhf497-bib-0113","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/ejhf.445","article-title":"Association of chronic kidney disease with abnormal cardiac mechanics and adverse outcomes in patients with heart failure and preserved ejection fraction","volume":"18","author":"Unger","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026011721151127200_ejhf497-bib-0114","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.ehj.2004.06.006","article-title":"Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey","volume":"25","author":"Lenzen","year":"2004","journal-title":"Eur Heart J"},{"key":"2026011721151127200_ejhf497-bib-0115","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.amjcard.2006.08.042","article-title":"Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study","volume":"99","author":"Ahmed","year":"2007","journal-title":"Am J Cardiol"},{"key":"2026011721151127200_ejhf497-bib-0116","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1056\/NEJMoa0805450","article-title":"Irbesartan in patients with heart failure and preserved ejection fraction","volume":"359","author":"Massie","year":"2008","journal-title":"N Engl J Med"},{"key":"2026011721151127200_ejhf497-bib-0117","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1161\/CIRCHEARTFAILURE.112.972794","article-title":"Baseline characteristics of patients in the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial","volume":"6","author":"Shah","year":"2013","journal-title":"Circ Heart Fail"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fejhf.497","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ejhf.497","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ejhf.497","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/18\/6\/588\/66381100\/eurjhf_18_6_588.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/18\/6\/588\/66381100\/eurjhf_18_6_588.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T02:15:59Z","timestamp":1768702559000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/article\/18\/6\/588\/8423357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,10]]},"references-count":117,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,2,10]]},"published-print":{"date-parts":[[2016,6,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ejhf.497","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,6]]},"published":{"date-parts":[[2016,2,10]]}}}